Tadalafil (Cialis) Has Lower Flushing Rates Than Sildenafil but Similar Efficacy—Switch to Tadalafil
If sildenafil causes flushing and doesn't help your ED, switching to tadalafil is a reasonable next step because it has significantly lower flushing rates (2-3% vs 7% with sildenafil), though efficacy across all PDE5 inhibitors is similar. 1, 2, 3
Why Tadalafil May Be Different for Side Effects
The FDA drug label data and recent large-scale studies show clear differences in adverse event profiles between these medications:
- Flushing occurs less frequently with tadalafil: Only 1-3% of patients on tadalafil 5-20mg experience flushing compared to 7.3% on sildenafil 2, 3
- Tadalafil causes more reflux/dyspepsia: 8% vs 5.3% with sildenafil, so if you have GERD, this matters 3
- Back pain and myalgia are more common with tadalafil: 2-6% depending on dose 2
A 2026 real-world study of 132,100 patients confirmed tadalafil and sildenafil have similar overall adverse event rates (33.9% vs 35%), but the types of side effects differ significantly 3. The most recent 2017 meta-analysis of head-to-head trials found tadalafil had lower flushing rates but higher myalgia/back pain rates compared to sildenafil 4.
Why the ED May Not Have Improved
Before switching medications, ensure you're using sildenafil correctly—improper use accounts for a large percentage of treatment failures 1:
- Sexual stimulation is required for any PDE5 inhibitor to work
- Avoid large/fatty meals before taking sildenafil (doesn't affect tadalafil) 5
- Multiple attempts needed: More than one trial may be required to establish efficacy
- Dose optimization is critical: If you tried only 25-50mg sildenafil, titrating to 100mg may improve response 1
The 2018 AUA Guidelines emphasize that all PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) have similar efficacy in the general ED population 1. A 2025 randomized controlled trial found daily tadalafil superior to on-demand sildenafil for erectile function, particularly penetration success 6, though this may reflect the pharmacokinetic advantage of continuous dosing rather than inherent superiority.
Practical Switching Strategy
Start tadalafil 10mg on-demand, titrate to 20mg if needed 1:
- Tadalafil's 17.5-hour half-life vs sildenafil's 4-hour half-life allows more spontaneity 5, 7
- Consider daily tadalafil 5mg if you prefer not timing doses around sexual activity—equally effective as on-demand dosing 8, 6, 9
- Food doesn't affect tadalafil absorption, unlike sildenafil 5
Important Caveats
If tadalafil also fails to improve ED, the problem may not be medication choice:
- Severe ED (from diabetes, post-prostatectomy) responds less robustly to all PDE5 inhibitors 1
- Consider underlying cardiovascular disease—ED is a risk marker for cardiac events as strong as smoking 1
- Evaluate for testosterone deficiency, which impairs PDE5 inhibitor response 1
- If two different PDE5 inhibitors fail at optimal doses with proper use, move to second-line therapies (intraurethral/intracavernosal agents, vacuum devices, penile prosthesis) rather than trying a third PDE5 inhibitor
Never combine PDE5 inhibitors or use with nitrates 2. The 2025 EAU Guidelines note that while PDE5 inhibitors share mechanisms, individual patient response varies, justifying therapeutic trials of different agents 8.
Recent 2024 data suggest tadalafil may offer additional cardiovascular and cognitive benefits beyond ED treatment, with reduced risks of mortality, MI, stroke, and dementia compared to sildenafil 10, though this shouldn't drive ED treatment decisions primarily.